PRME
PRME clinical trials: Prime Medicine, Inc.
Every trial on ClinicalTrials.gov where Prime Medicine, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PRME on the catalyst calendar · PRME registry changes
- Primary completion Dec 2028Sponsor estimatePhase 1/Phase 2NCT07887347A Study of the Safety and Efficacy of Prime Editing (PM647a) in Participants With Alpha-1 Antitrypsin DeficiencyPrime Medicine, Inc. · Alpha-1 Antitrypsin DeficiencyNot yet recruitingPRMELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2028Sponsor estimatePhase 1/Phase 2NCT07748403A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)Prime Medicine, Inc. · Wilson DiseaseRecruitingPRMELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimateNo phase registeredNCT07226622Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical TrialPrime Medicine, Inc. · Wilson DiseaseActive, not recruitingPRMELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2030Sponsor estimatePhase 1/Phase 2NCT06559176A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous...Prime Medicine, Inc. · Chronic Granulomatous DiseaseEnrolling by invitationPRMELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner